Engineering methods in vivo to sensitize breast cancer cells to death
Undertanding parity-induced changes in the human breast and how these changes can be harnessed to improve prevention and treatment strategies. In particular, my lab focuses on pathways that sensitize cells to apoptosis and alter growth and motility, such as the tumor suppressor p53, the family of wnt antagonists, and TGFbeta family members.
|
